{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190725",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "59473",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/211215Orig1s000ltr.pdf",
              "date": "20190726",
              "type": "Letter"
            },
            {
              "id": "59499",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211215s000lbl.pdf",
              "date": "20190730",
              "type": "Label"
            },
            {
              "id": "62107",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211215Orig1s000TOC.html",
              "date": "20200310",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20230509",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "74204",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/211215Orig1s002ltr.pdf",
              "date": "20230510",
              "type": "Letter"
            },
            {
              "id": "74209",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211215Orig1s002lbl.pdf",
              "date": "20230510",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA211215",
      "sponsor_name": "MAIA PHARMS INC",
      "openfda": {
        "application_number": [
          "NDA211215"
        ],
        "brand_name": [
          "BIVALIRUDIN"
        ],
        "generic_name": [
          "BIVALIRUDIN"
        ],
        "manufacturer_name": [
          "MAIA Pharmaceuticals, Inc.",
          "Endo USA, Inc."
        ],
        "product_ndc": [
          "70511-142",
          "42023-622"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "BIVALIRUDIN"
        ],
        "rxcui": [
          "1997015"
        ],
        "spl_id": [
          "c727199d-f4cd-4658-8fdf-568590beface",
          "e7641caf-d2f1-4a0e-a559-cd14aed68548"
        ],
        "spl_set_id": [
          "c727199d-f4cd-4658-8fdf-568590beface",
          "91cf9d00-29e0-4357-a184-f70026c47edb"
        ],
        "package_ndc": [
          "70511-142-50",
          "70511-142-84",
          "42023-622-01",
          "42023-622-10"
        ],
        "nui": [
          "N0000175980",
          "N0000175518",
          "N0000009963"
        ],
        "pharm_class_epc": [
          "Anti-coagulant [EPC]",
          "Direct Thrombin Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Thrombin Inhibitors [MoA]"
        ],
        "unii": [
          "TN9BEX005G"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ANGIOMAX RTU",
          "active_ingredients": [
            {
              "name": "BIVALIRUDIN",
              "strength": "250MG/50ML (5MG/ML)"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "SOLUTION",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}